
Inorganica Chimica Acta p. 133 - 136 (1998)
Update date:2022-08-02
Topics:
Schuette, Mark Thomas
Schumacher, Peter
Unger, Clemens
Muelhaupt, Rolf
Kratz, Felix
By attaching maleimide groups to anticancer drugs, derivatives are obtained which bind selectively to thiolated carrier proteins. Two maleimide ester derivatives of platinum(II) complexes which consist of an active cis-configurated platinum(II) moiety and a maleimide group capable of binding to thiolated carriers were prepared, i.e. N-(O-(3-maleimidobenzoyl)-2-hydroxyethyl)-1,2-diaminoethanedichloroplatinum(II) (7) and N-(O-(2-(4-maleimidophenyl)acetyl)-2-hydroxyethyl)-1,2- diaminoethanedichloroplatinum(II) (8). 7 and 8 were characterized through 1H and 13C NMR spectroscopy, IR spectroscopy, elemental analysis and mass spectrometry (FAB).
Contact:86-27-84888681
Address:Wuhan economic & technology development zone
CGeneTech (Suzhou, China) Co., Ltd.
Contact:+86-512-62956962
Address:Room 101,Bld C11,218 Xinghu Rd.,Suzhou industrial Park
Daicel Chiral Technologies (China)CO.,LTD
Contact:021-5046-0086*8
Address:Part C, FL 5, the 16th Building, No. 69, XiYa Road, WaiGaoQiao Free Trade Zone, Shanghai, 200131, P.R.China
Sinoway International (Jiangsu) Co., Ltd.
Contact:+86-25-86630167
Address:17 Beijing Road (West), Nanjing, China
LianYunGang Chiral Chemical(CHINA) CO.,LTD
Contact:+86-518-83616958 +86-519-82884848
Address:LianYunGang Chemical Industry Park (JiangSu)
Doi:10.1039/c3dt50310k
(2013)Doi:10.1038/nchem.1469
(2012)Doi:10.1021/ja01358a034
(1931)Doi:10.1021/acs.orglett.6b03155
(2016)Doi:10.1021/om010160z
(2001)Doi:10.1007/BF00905567
()